These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15555994)

  • 1. Engineering switches, genetically.
    Roberts RW
    Chem Biol; 2004 Nov; 11(11):1475-6. PubMed ID: 15555994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A molecular switch created by in vitro recombination of nonhomologous genes.
    Guntas G; Mitchell SF; Ostermeier M
    Chem Biol; 2004 Nov; 11(11):1483-7. PubMed ID: 15555998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Directed evolution of protein switches and their application to the creation of ligand-binding proteins.
    Guntas G; Mansell TJ; Kim JR; Ostermeier M
    Proc Natl Acad Sci U S A; 2005 Aug; 102(32):11224-9. PubMed ID: 16061816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of effector affinity by hinge region mutations also modulates switching activity in an engineered allosteric TEM1 beta-lactamase switch.
    Kim JR; Ostermeier M
    Arch Biochem Biophys; 2006 Feb; 446(1):44-51. PubMed ID: 16384549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-guided SCHEMA recombination of distantly related beta-lactamases.
    Meyer MM; Hochrein L; Arnold FH
    Protein Eng Des Sel; 2006 Dec; 19(12):563-70. PubMed ID: 17090554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface-tethered protein switches.
    Zayats M; Kanwar M; Ostermeier M; Searson PC
    Chem Commun (Camb); 2011 Mar; 47(12):3398-400. PubMed ID: 21331440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro recombination of non-homologous genes can result in gene fusions that confer a switching phenotype to cells.
    Heins RA; Choi JH; Sohka T; Ostermeier M
    PLoS One; 2011; 6(11):e27302. PubMed ID: 22096548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand interaction scan: a general method for engineering ligand-sensitive protein alleles.
    Erster O; Eisenstein M; Liscovitch M
    Nat Methods; 2007 May; 4(5):393-5. PubMed ID: 17450147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering allosteric protein switches by domain insertion.
    Ostermeier M
    Protein Eng Des Sel; 2005 Aug; 18(8):359-64. PubMed ID: 16043448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-allosteric enzyme switches possess larger effector-induced changes in thermodynamic stability than their non-switch analogs.
    Choi JH; San A; Ostermeier M
    Protein Sci; 2013 Apr; 22(4):475-85. PubMed ID: 23400970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modular protein switches derived from antibody mimetic proteins.
    Nicholes N; Date A; Beaujean P; Hauk P; Kanwar M; Ostermeier M
    Protein Eng Des Sel; 2016 Feb; 29(2):77-85. PubMed ID: 26637825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic protein switches built from paralogous input domains.
    Tullman J; Nicholes N; Dumont MR; Ribeiro LF; Ostermeier M
    Biotechnol Bioeng; 2016 Apr; 113(4):852-8. PubMed ID: 26461040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of ecdysone receptor gene switches in mammalian cells.
    Panguluri SK; Kumar P; Palli SR
    FEBS J; 2006 Dec; 273(24):5550-63. PubMed ID: 17096690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interplay between effector binding and allostery in an engineered protein switch.
    Choi JH; Xiong T; Ostermeier M
    Protein Sci; 2016 Sep; 25(9):1605-16. PubMed ID: 27272021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The high-affinity maltose switch MBP317-347 has low affinity for glucose: implications for targeting tumors with metabolically directed enzyme prodrug therapy.
    Valdes G; Schulte RW; Ostermeier M; Iwamoto KS
    Chem Biol Drug Des; 2014 Mar; 83(3):266-71. PubMed ID: 24131788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and evolution of new catalytic activity with an existing protein scaffold.
    Park HS; Nam SH; Lee JK; Yoon CN; Mannervik B; Benkovic SJ; Kim HS
    Science; 2006 Jan; 311(5760):535-8. PubMed ID: 16439663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tying up the loose ends: circular permutation decreases the proteolytic susceptibility of recombinant proteins.
    Whitehead TA; Bergeron LM; Clark DS
    Protein Eng Des Sel; 2009 Oct; 22(10):607-13. PubMed ID: 19622546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Library analysis of SCHEMA-guided protein recombination.
    Meyer MM; Silberg JJ; Voigt CA; Endelman JB; Mayo SL; Wang ZG; Arnold FH
    Protein Sci; 2003 Aug; 12(8):1686-93. PubMed ID: 12876318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational design of a fusion protein to exhibit disulfide-mediated logic gate behavior.
    Choi JH; Ostermeier M
    ACS Synth Biol; 2015 Apr; 4(4):400-6. PubMed ID: 25144732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid and easy development of versatile tools to study protein/ligand interactions.
    Vandevenne M; Gaspard G; Yilmaz N; Giannotta F; Frère JM; Galleni M; Filée P
    Protein Eng Des Sel; 2008 Jul; 21(7):443-51. PubMed ID: 18456870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.